Daily COVID-19 Vaccinations Could Nearly Double by the End of March if Supply Keeps Up
This policy watch looks at the expected ramp up in vaccine supply, and what this could mean for increasing the number of people getting vaccinated.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Health Policy 101 is a comprehensive guide covering fundamental aspects of U.S. health policy and programs, including Medicare, Medicaid, the Affordable Care Act, employer-sponsored insurance, the uninsured population, health care costs and affordability, women's health issues, and health care politics. The Public Health chapter examines how public health is governed and delivered in the United States. It includes explanations of key public health frameworks, services, capabilities and characteristics, how the public health system works in state, local and territorial governments, and public health funding, workforce, and communication challenges in an era of declining trust.
This policy watch looks at the expected ramp up in vaccine supply, and what this could mean for increasing the number of people getting vaccinated.
This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.
People with medical conditions that put them at higher risk of developing serious COVID-19 illness are next in line to get vaccinated in many states, though states are making very different choices about how to prioritize those within this large group, finds a KFF analysis of state policies. The U.S. Centers for Disease Control and Prevention (CDC) estimates that there are 81 million adults nationwide with conditions that it identifies as posing an increased risk…
Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations. The latest analysis from the KFF COVID-19 Vaccine Monitor highlights how attitudes differ by partisan identification and race and ethnicity in ways that could affect what vaccination messages are most persuasive to subgroups. For example: Republicans and Republican-leaning independents…
Thirty-one percent of the public wants to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves. While they share a similar level of vaccine hesitancy, this group is not monolithic in their attitudes and beliefs. This brief examines how people with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and may respond differently to messages…
This report summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19 vaccine and the views of the messages and messengers that could affect their willingness to get one,
As the country broadens COVID-19 vaccine distribution efforts, the latest research from the KFF COVID-19 Vaccine Monitor finds that side effects, including allergic reactions and long-term consequences, are the public’s top concern about getting vaccinated when asked to describe what worries them in their own words. The latest report from the KFF COVID-19 Vaccine Monitor summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19…
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
Despite Optimism about COVID-19 Vaccines in the Future, Half Say They are Frustrated with the Current Situation and Nearly a Quarter are Angry While older Americans are a high-priority group for getting a COVID-19 vaccine, the latest KFF COVID-19 Vaccine Monitor report finds that, among those who have not yet been vaccinated, most people ages 65 and older say they do not have enough information about when (58%) and where (59%) they will be able to get…
This KFF COVID-19 Vaccine Monitor report shows nearly half of the public now wants to get a vaccine as soon as possible, reflecting a rise in enthusiasm across racial and ethnic groups since December. It also examines information needs, worries about the vaccine, effective messages and views of vaccine distribution.
© 2026 KFF
